<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052920</url>
  </required_header>
  <id_info>
    <org_study_id>201612147</org_study_id>
    <nct_id>NCT03052920</nct_id>
  </id_info>
  <brief_title>Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial</brief_title>
  <official_title>Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Midwest Ear Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>House Clinic, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This longitudinal study evaluates the possible benefit of cochlear implantation in the poor&#xD;
      ear of adults with asymmetric hearing loss who continue to use a hearing aid in the better&#xD;
      hearing ear.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted as a multicenter, prospective, single-arm clinical trial,&#xD;
      evaluating the efficacy and safety of cochlear implantation in patients with asymmetric&#xD;
      hearing loss. A repeated-measures analysis will be employed whereby patients will act as&#xD;
      their own controls. Participants will be recruited from surgeons and audiologists in&#xD;
      Otolaryngology departments at the participating sites.&#xD;
&#xD;
      Participants will be evaluated at multiple intervals using a variety of test measures&#xD;
      (addressing sound localization, understanding speech in noise, understanding speech in quiet,&#xD;
      and quality of life).&#xD;
&#xD;
      Prior to receiving a cochlear implant (CI) in the poor hearing ear, participants will be&#xD;
      evaluated as follows:&#xD;
&#xD;
        -  Hearing aid (HA) in the better ear alone&#xD;
&#xD;
        -  HA in the poor ear alone&#xD;
&#xD;
        -  Bilateral HAs&#xD;
&#xD;
      Participants who have not previously used a poor-ear hearing aid or BiCROS hearing aid will&#xD;
      complete a 1-2 week trial and be evaluated at the end of the trial. If performance is better&#xD;
      with the alternate therapy (bilateral hearing aids or BiCROS hearing aid) than the better ear&#xD;
      alone performance and the participant prefers the alternate therapy, the participant will not&#xD;
      continue in the study.&#xD;
&#xD;
      Participants who do continue in the study will be evaluated at several post-implant&#xD;
      intervals. Post-implant evaluations will occur at 3, 6, 9, and 12 months after initial&#xD;
      stimulation of the CI. Participants will be evaluated as follows:&#xD;
&#xD;
        -  HA in the better ear alone&#xD;
&#xD;
        -  CI in the poor ear alone&#xD;
&#xD;
        -  HA and CI together&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 28, 2017</start_date>
  <completion_date type="Actual">March 10, 2021</completion_date>
  <primary_completion_date type="Actual">November 17, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Group mean difference in CNC monosyllabic word understanding score in quiet with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (Positive scores indicate improvement.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sound Localization</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Sound localization post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AzBio Sentences at 50 Decibels (dB) Sound Pressure Level (SPL)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Understanding of sentences at a soft presentation level post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AzBio Sentences at 60 dB SPL and 4-talker Babble at +8 dB Signal-to-noise Ratio (SNR)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Understanding of sentences in noise post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentences With Noise to the Better Ear and With Noise to the Poor Ear</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Understanding of sentences in noise post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AzBio Sentences at 60 dB SPL</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>AzBio sentence understanding in quiet with the CI alone compared to pre-implant with a hearing aid.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hearing Handicap Inventory (HHIE)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Inventory completed by participant regarding emotional and social consequences of hearing loss.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Utility Index (HUI3)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Questionnaire completed by participant regarding ability/disability across several health dimensions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech, Spatial and Sound Qualities (SSQ)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Questionnaire completed by participant regarding impact of hearing loss on various listening situations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech, Spatial and Sound Qualities (SSQ)</measure>
    <time_frame>Pre-implant and 12 months post-implant</time_frame>
    <description>Questionnaire completed by participant regarding impact of hearing loss on various listening situations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow Benefit Inventory (GBI)</measure>
    <time_frame>6 months post-implant</time_frame>
    <description>Inventory completed by participant regarding perceived benefit of cochlear implantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Amplification in Daily Use (SADL)</measure>
    <time_frame>6 months post-implant</time_frame>
    <description>Questionnaire completed by participant regarding satisfaction of bimodal (HA+CI) device use. The original questionnaire wording has been modified for bimodal listeners.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questions From the Communication Profile for the Hearing Impaired (CPHI)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Questionnaire completed by participant's spouse/significant other indicating their perception of how well the participant communicates in various situations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hearing Impaired Impact - Significant Other Profile (HII-SOP)</measure>
    <time_frame>Pre-implant and 6 months post-implant</time_frame>
    <description>Questionnaire completed by participant's spouse/significant other indicating their perception of the impact of the participant's hearing loss on the spouse/significant other.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number, Type and Degree of Adverse Events</measure>
    <time_frame>Up through 6 months post-implant</time_frame>
    <description>Adverse event information through 6 months post-implant will be summarized by event type, severity/seriousness, and whether related to the device and/or implant procedure</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Cochlear Implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cochlear implantation of the poor hearing ear</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cochlear implant</intervention_name>
    <description>Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.</description>
    <arm_group_label>Cochlear Implantation</arm_group_label>
    <other_name>Cochlear America</other_name>
    <other_name>Advanced Bionics</other_name>
    <other_name>MED-EL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  English as the native language&#xD;
&#xD;
          -  Have a desire for functional binaural hearing&#xD;
&#xD;
          -  Have failed a previous hearing aid (HA) treatment for asymmetric hearing loss (BiCROS&#xD;
             or poor ear HA) or willing to complete a trial if necessary&#xD;
&#xD;
          -  Willingness to comply with all study requirements&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  Poor ear (ear to be implanted):&#xD;
&#xD;
               -  Pure-tone average (PTA) at .5, 1 and 2 kilohertz (kHz) &gt; 70 dB HL (hereafter&#xD;
                  referred to as severe to profound hearing loss - SPHL)&#xD;
&#xD;
               -  Aided word recognition score (CNC Word Test) at 60 dB SPL ≤ 30%&#xD;
&#xD;
               -  Duration of SPHL ≥ 6 months&#xD;
&#xD;
               -  Onset of hearing loss ≥ 6 years of age&#xD;
&#xD;
          -  Better ear:&#xD;
&#xD;
               -  PTA at .5, 1, 2, 4 kHz of 40 to 70 dB HL&#xD;
&#xD;
               -  Currently using a HA&#xD;
&#xD;
               -  Aided word recognition score (CNC Word Test) at 60 dB SPL &gt; 40%&#xD;
&#xD;
               -  Stable hearing for the previous 1-year period. &quot;Stable&quot; is defined as thresholds&#xD;
                  that have not changed by more than 10 dB at 2 or more octave interval audiometric&#xD;
                  frequencies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medical condition that contraindicates surgery&#xD;
&#xD;
          -  Actively using an implantable device in the ear to be implanted&#xD;
&#xD;
          -  Known cochlear malformation or obstruction that would preclude full insertion of the&#xD;
             electrode array in the ear to be implanted&#xD;
&#xD;
          -  Hearing loss of neural or central origin&#xD;
&#xD;
          -  Unrealistic expectations related to the benefits and limitations of cochlear&#xD;
             implantation&#xD;
&#xD;
          -  Unwillingness or inability to comply with all investigational requirements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jill B Firszt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>House Clinic</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Midwest Ear Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 9, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <results_first_submitted>September 1, 2021</results_first_submitted>
  <results_first_submitted_qc>October 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 18, 2021</results_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <keyword>asymmetric hearing loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 27, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/20/NCT03052920/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment occurred from Summer 2017 through 2019.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Cochlear Implantation</title>
          <description>Cochlear implantation of the poor hearing ear&#xD;
Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cochlear Implantation</title>
          <description>Cochlear implantation of the poor hearing ear&#xD;
Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.96" spread="10.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Length of Deafness - Poor Ear</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.18" spread="12.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet</title>
        <description>Group mean difference in CNC monosyllabic word understanding score in quiet with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (Positive scores indicate improvement.)</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
        <population>36 participants had both pre-implant and 6-month post-implant CNC scores for the poor ear alone.</population>
        <group_list>
          <group group_id="O1">
            <title>Cochlear Implantation</title>
            <description>Cochlear implantation of the poor hearing ear&#xD;
Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet</title>
          <description>Group mean difference in CNC monosyllabic word understanding score in quiet with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (Positive scores indicate improvement.)</description>
          <population>36 participants had both pre-implant and 6-month post-implant CNC scores for the poor ear alone.</population>
          <units>percentage of words correct</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Implant Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Post-Implant Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Group mean difference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.039"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Mean difference in percent correct for CNC words at 6 months post-implant minus pre-implant is reported.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>The threshold for statistical significance was &lt;=0.05</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>t(35) = 11.29</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sound Localization</title>
        <description>Sound localization post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AzBio Sentences at 50 Decibels (dB) Sound Pressure Level (SPL)</title>
        <description>Understanding of sentences at a soft presentation level post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AzBio Sentences at 60 dB SPL and 4-talker Babble at +8 dB Signal-to-noise Ratio (SNR)</title>
        <description>Understanding of sentences in noise post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentences With Noise to the Better Ear and With Noise to the Poor Ear</title>
        <description>Understanding of sentences in noise post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AzBio Sentences at 60 dB SPL</title>
        <description>AzBio sentence understanding in quiet with the CI alone compared to pre-implant with a hearing aid.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hearing Handicap Inventory (HHIE)</title>
        <description>Inventory completed by participant regarding emotional and social consequences of hearing loss.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Utility Index (HUI3)</title>
        <description>Questionnaire completed by participant regarding ability/disability across several health dimensions.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Speech, Spatial and Sound Qualities (SSQ)</title>
        <description>Questionnaire completed by participant regarding impact of hearing loss on various listening situations.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Speech, Spatial and Sound Qualities (SSQ)</title>
        <description>Questionnaire completed by participant regarding impact of hearing loss on various listening situations.</description>
        <time_frame>Pre-implant and 12 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glasgow Benefit Inventory (GBI)</title>
        <description>Inventory completed by participant regarding perceived benefit of cochlear implantation.</description>
        <time_frame>6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Amplification in Daily Use (SADL)</title>
        <description>Questionnaire completed by participant regarding satisfaction of bimodal (HA+CI) device use. The original questionnaire wording has been modified for bimodal listeners.</description>
        <time_frame>6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Questions From the Communication Profile for the Hearing Impaired (CPHI)</title>
        <description>Questionnaire completed by participant's spouse/significant other indicating their perception of how well the participant communicates in various situations.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hearing Impaired Impact - Significant Other Profile (HII-SOP)</title>
        <description>Questionnaire completed by participant's spouse/significant other indicating their perception of the impact of the participant's hearing loss on the spouse/significant other.</description>
        <time_frame>Pre-implant and 6 months post-implant</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number, Type and Degree of Adverse Events</title>
        <description>Adverse event information through 6 months post-implant will be summarized by event type, severity/seriousness, and whether related to the device and/or implant procedure</description>
        <time_frame>Up through 6 months post-implant</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Approximately 15 months, from enrollment until 12-month evaluation.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cochlear Implantation</title>
          <description>Cochlear implantation of the poor hearing ear&#xD;
Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart bypass surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gall bladder removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Result of anesthesia</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>at surgical site</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Tear of medial meniscus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Kidney stone removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Coronary angioplasty and stint</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>onset or worsening</description>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <description>onset or worsening</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <description>Swelling over the cochlear implant receiver/stimulator</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jill B Firszt, PI</name_or_title>
      <organization>Washington University in St. Luis</organization>
      <phone>314-362-4760</phone>
      <email>FirsztJ@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

